Current classification criteria for definite antiphospholipid syndrome (APS) mandate the use
of one or more of three positive 'standardized'laboratory assays to detect antiphospholipid …

Current classification criteria for definite APS recommend the use of one or more of three
positive standardized laboratory assays, including anticardiolipin antibodies (aCL), lupus …

Positive results in the anticardiolipin antibody (aCL), anti-β 2-glycoprotein I antibody (aβ 2
GPI), and/or lupus anticoagulant (LA) assays constitute the laboratory criteria for the definite …

The updated international consensus criteria for definite antiphospholipid syndrome (APS)
are useful for scientific clinical studies. However, there remains a need for diagnostic criteria …

The antiphospholipid syndrome (APS) is an autoimmune condition characterized by
vascular thromboses and/or pregnancy morbidity, and its diagnosis currently requires …

Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion
(thrombosis and/or pregnancy morbidity), combined with persistently circulating …

The antiphospholipid syndrome (APS) is defined by thrombotic and/or obstetric events
together with the presence of antiphospholipid antibodies in plasma of patients. The original …

The antiphospholipid syndrome (APS) is an autoimmune condition characterised by a wide
range of clinical features (primarily thrombosis and/or obstetric related), associated with the …

Over 30 years since it was first described as a discrete clinical entity, the antiphospholipid
antibody syndrome (APS) remains a challenge for both laboratory workers and clinicians in …

The measurement of antiphospholipid antibodies (aPL) has been an important aspect of
antiphospholipid syndrome (APS) characterization since the disease was first described in …